415 related articles for article (PubMed ID: 33167940)
1. Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis.
Luo J; Liu P; Wang L; Huang Y; Wang Y; Geng W; Chen D; Bai Y; Yang Z
BMC Cancer; 2020 Nov; 20(1):1071. PubMed ID: 33167940
[TBL] [Abstract][Full Text] [Related]
2. Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanisms.
Chen S; Cao GD; Wei W; Yida L; Xiaobo H; Lei Y; Ke C; Chen B; Xiong MM
World J Surg Oncol; 2020 Jun; 18(1):146. PubMed ID: 32600423
[TBL] [Abstract][Full Text] [Related]
3. Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms.
Liang W; Yang X; Li X; Wang P; Zhu Z; Liu S; Xu D; Zhi X; Xue J
Aging (Albany NY); 2024 May; 16(9):7596-7621. PubMed ID: 38742936
[TBL] [Abstract][Full Text] [Related]
4. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
[No Abstract] [Full Text] [Related]
5. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
Jin L; Li C; Liu T; Wang L
Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
[TBL] [Abstract][Full Text] [Related]
6. Identification prognosis-associated immune genes in colon adenocarcinoma.
Miao Y; Wang J; Ma X; Yang Y; Mi D
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
Front Immunol; 2021; 12():665002. PubMed ID: 34367132
[TBL] [Abstract][Full Text] [Related]
8. A pairwise immune gene model for predicting overall survival and stratifying subtypes of colon adenocarcinoma.
Jiang Z; Xu J; Zhang S; Lan H; Bao Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10813-10829. PubMed ID: 37316691
[TBL] [Abstract][Full Text] [Related]
9. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
[TBL] [Abstract][Full Text] [Related]
10. Identification and validation of regulatory T cell-associated gene signatures to predict colon adenocarcinoma prognosis.
Zhao X; Li X; Miao Z
Int Immunopharmacol; 2024 May; 132():112034. PubMed ID: 38588631
[TBL] [Abstract][Full Text] [Related]
11. Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma.
Ouyang R; Li Z; Peng P; Zhang J; Liu J; Qin M; Huang J
Int J Med Sci; 2021; 18(3):685-694. PubMed ID: 33437203
[No Abstract] [Full Text] [Related]
12. To explore the prognostic characteristics of colon cancer based on tertiary lymphoid structure-related genes and reveal the characteristics of tumor microenvironment and drug prediction.
Wang Z; Niu D
Sci Rep; 2024 Jun; 14(1):13555. PubMed ID: 38867070
[TBL] [Abstract][Full Text] [Related]
13. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
Huang W; Liu Z; Li Y; Liu L; Mai G
J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
[TBL] [Abstract][Full Text] [Related]
14. Identification and Verification of a 17 Immune-Related Gene Pair Prognostic Signature for Colon Cancer.
Zhang Q; Feng Z; Zhang Y; Shi S; Zhang Y; Ren S
Biomed Res Int; 2021; 2021():6057948. PubMed ID: 34124251
[TBL] [Abstract][Full Text] [Related]
15. Mining novel cell glycolysis related gene markers that can predict the survival of colon adenocarcinoma patients.
Chen S; Cao G; Wu W; Lu Y; He X; Yang L; Chen K; Chen B; Xiong M
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744303
[TBL] [Abstract][Full Text] [Related]
16. Gene expression and methylation profiles identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis of colon adenocarcinoma.
Zhao QQ; Jiang C; Gao Q; Zhang YY; Wang G; Chen XP; Wu SB; Tang J
J Cell Physiol; 2020 May; 235(5):4902-4912. PubMed ID: 31709538
[TBL] [Abstract][Full Text] [Related]
17. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma.
Yang M; He H; Peng T; Lu Y; Yu J
Comput Intell Neurosci; 2022; 2022():8598046. PubMed ID: 35392038
[TBL] [Abstract][Full Text] [Related]
18. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
19. Prognostic risk assessment model and drug sensitivity analysis of colon adenocarcinoma (COAD) based on immune-related lncRNA pairs.
Hao Z; Liang P; He C; Sha S; Yang Z; Liu Y; Shi J; Zhu Z; Chang Q
BMC Bioinformatics; 2022 Oct; 23(1):435. PubMed ID: 36258178
[TBL] [Abstract][Full Text] [Related]
20. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.
Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J
Front Immunol; 2022; 13():881359. PubMed ID: 35911752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
